Lu Yang
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- Molecular Biology top 5%
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
Papers in
-
- Breast Cancer Treatment Studies 12
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 7
- Oncology 15
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Hailin Tang (20 shared papers)Xiaoming Xie (22 shared papers)Xinhua Xie (16 shared papers)Yanan Kong (8 shared papers)Xiaojia Huang (10 shared papers)Jin Wang (3 shared papers)Yingming Zhao (2 shared papers)Jixiang Ding (1 shared paper)
- Journals
- PLoS ONE (6 papers)Cancer Letters (4 papers)Frontiers in Oncology (3 papers)Cell Death and Disease (3 papers)Frontiers in Cell and Developmental Biology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lu Yang
82 papers receiving 3.9k citations
Lu Yang's Hit Papers
Peers
Comparison fields: 5 of 97
- Cancer Research 1.2k
- Molecular Biology 1.7k
- Oncology 550
- Drug Discovery 5
- Pulmonary and Respiratory Medicine 291
Countries citing papers authored by Lu Yang
This map shows the geographic impact of Lu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Yang more than expected).
Fields of papers citing papers by Lu Yang
This network shows the impact of papers produced by Lu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Yang. The network helps show where Lu Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Class I histone deacetylases (HDAC1–3) are histone lysine delactylases Hit paper breakdown → | 2022 | 579 |
| 2 | 2000 | 328 | |
| 3 | 2018 | 223 | |
| 4 | 2017 | 209 | |
| 5 | N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer Hit paper breakdown → | 2022 | 197 |
| 6 | 2019 | 168 | |
| 7 | 2015 | 139 | |
| 8 | 2022 | 130 | |
| 9 | 2021 | 124 | |
| 10 | 2022 | 120 | |
| 11 | 2013 | 112 | |
| 12 | 2014 | 102 | |
| 13 | 2020 | 93 | |
| 14 | 2014 | 91 | |
| 15 | 2014 | 86 | |
| 16 | 2015 | 84 | |
| 17 | 2016 | 76 | |
| 18 | 2019 | 74 | |
| 19 | 2015 | 70 | |
| 20 | 2017 | 54 |
About Lu Yang
Lu Yang is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Biomaterials, having authored 88 papers that have together received 4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Circular RNAs in diseases (8 papers), MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers), Prostate Cancer Treatment and Research (5 papers), Nanoparticle-Based Drug Delivery (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.7k citations), Oncology (550 citations), Drug Discovery (5 citations) and Pulmonary and Respiratory Medicine (291 citations). Lu Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hailin Tang, Xiaoming Xie, Xinhua Xie, Yanan Kong, Xiaojia Huang, Jin Wang, Yingming Zhao, Jixiang Ding, Shobhna Gopal-Truter and Michael M. Shen. Their work appears in journals such as PLoS ONE, Cancer Letters, Frontiers in Oncology, Cell Death and Disease and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.